Showing results (61-70 of 114) with videos related to
Sort By:
Pageof 12
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 23, 2018
Reappraisal of HER2 status in the spectrum of advanced urothelial carcinoma: a need of guidelines for treatment eligibilityAnissa Moktefi, Damien Pouessel, Jing Liu, et al.Urology|May 5, 2011
Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancerEvan Y Yu, Christophe Massard, Mitchell E Gross, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancerEvan Y Yu, George Wilding, Edwin Posadas, et al.European Urology|October 8, 2013
A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective studyKarim Fizazi, Rémi Delva, Armelle Caty, et al.European Journal of Clinical Pharmacology|January 15, 2020
Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitorsCamille Azam, Pauline Claraz, Christine Chevreau, et al.Critical Reviews in Oncology/Hematology|July 28, 2026
Squamous cell carcinoma of the bladder: Current evidence, therapeutic challenges, and research perspectives from the French AVENTUR groupJérémy Mercier, Pierre Cornillon, Philippe Barthélémy, et al.Journal of Clinical Medicine|June 27, 2020
Survival Outcomes of Patients with Pathologically Proven Positive Lymph Nodes at Time of Radical Cystectomy with or without Neoadjuvant ChemotherapyGuillaume Ploussard, Benjamin Pradere, Jean-Baptiste Beauval, et al.European Urology|September 15, 2014
Achievements and perspectives in prostate cancer phase 3 trials from genitourinary research groups in Europe: introducing the Prostate Cancer Consortium in EuropeKarim Fizazi, Per-Anders Abrahamsson, Goran Ahlgren, et al.Cancer Medicine|April 21, 2025
Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer PatientsSoufyan Annakib, Emma Di Méglio, Yona Dibert-Bekoy, et al.Oncotarget|September 22, 2018
Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8+ T cellsFrancois Desgrandchamps, Joel LeMaoult, Annabelle Goujon, et al.Pageof 12